<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77225">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01896245</url>
  </required_header>
  <id_info>
    <org_study_id>A 2013-0039</org_study_id>
    <nct_id>NCT01896245</nct_id>
  </id_info>
  <brief_title>Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant)</brief_title>
  <acronym>SEVODosage</acronym>
  <official_title>Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rostock</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anesthesia induction and tracheal intubation can be performed with and without neuromuscular
      blocking agents (NMBAs). Tracheal intubation can be performed with sevoflurane instead of
      NMBAs; intubating conditions are similar and the incidence of vocal cord injuries are
      similar, too.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>incidence of vocal cord injuries</measure>
    <time_frame>24 hours after tracheal intubation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of hoarseness</measure>
    <time_frame>24, 48, and 72 hours after tracheal intubation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of soar throat</measure>
    <time_frame>24, 48, and 72 hours after tracheal intubation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Vocal Cord Injuries</condition>
  <arm_group>
    <arm_group_label>sevoflurane 0,8</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sevoflurane 0,8: sevoflurane is administered with a concentration of 0,8 MAC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane 1,0</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sevoflurane 1,0: sevoflurane is administered with a concentration of 0,8 MAC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane 1,2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sevoflurane 1,2: sevoflurane is administered with a concentration of 0,8 MAC</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane 0,8</intervention_name>
    <description>anesthesia induction with propofol, remifentanil, and sevoflurane 0,8 MAC; afterwards tracheal intubation</description>
    <arm_group_label>sevoflurane 0,8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane 1,0</intervention_name>
    <description>anesthesia induction with propofol, remifentanil, and sevoflurane 1,0 MAC; afterwards tracheal intubation</description>
    <arm_group_label>sevoflurane 1,0</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane 1,2</intervention_name>
    <description>anesthesia induction with propofol, remifentanil, and sevoflurane 1,2 MAC; afterwards tracheal intubation</description>
    <arm_group_label>sevoflurane 1,2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ear-nose-throat surgery

          -  orotracheal intubation for surgery of the ear

          -  ASA I-III

        Exclusion Criteria:

          -  obesity

          -  allergy against the study drugs

          -  patients with a known or suspected difficult airway

          -  diseases of the larynx
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Mencke, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dep. of Anesthesia and Intensive Care Medicine, University of Rostock, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Mencke, Dr.</last_name>
    <phone>+49 381 494 6411</phone>
    <email>thomas.mencke@googlemail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ilona Bicker</last_name>
    <phone>+49 381 494 6411</phone>
    <email>ilona.bicker@web.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesia and Intensive Care Medicine, University of Rostock</name>
      <address>
        <city>Rostock</city>
        <state>Mecklenburg/Vorpommern</state>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Mencke</last_name>
    </contact>
    <contact_backup>
      <last_name>Ilona Bicker</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ilona Bicker</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Refa Jacobs</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 13, 2013</lastchanged_date>
  <firstreceived_date>July 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rostock</investigator_affiliation>
    <investigator_full_name>Thomas Mencke</investigator_full_name>
    <investigator_title>Clinical Associate Professor Dr Thomas Mencke</investigator_title>
  </responsible_party>
  <keyword>hoarseness</keyword>
  <keyword>sore throat</keyword>
  <keyword>intubating conditions</keyword>
  <keyword>vocal cord injuries</keyword>
  <keyword>sevoflurane</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscle Hypotonia</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
